Hospira is the world's leading provider of injectable drugs and infusion technologies. Through our broad, integrated portfolio, we are uniquely positioned to Advance Wellness™ by improving patient and caregiver safety while reducing healthcare costs. Through our offering of high-quality, lower-cost generic medications, we continue to help reduce the overall costs of healthcare — to improve both the affordability of care for patients and the financial strength of the global healthcare system. By working with our device customers to integrate technologies at the point of care, we are the partner of choice for improving patient and caregiver safety, clinical outcomes, cost management, as well as caregiver efficiency and effectiveness. Additionally, our One2One™ business is a leading provider of contract manufacturing services to proprietary pharmaceutical and biotechnology companies for formulation development, filling and finishing of injectable pharmaceuticals.
Type
Subsidiary
Parent Company
Pfizer
HQ
Lake Forest, US
Hospira is headquartered in Lake Forest, US
Report incorrect company information

Hospira Office Locations

Hospira has an office in Lake Forest
Lake Forest, US (HQ)
275 N Field Dr
Show all (1)
Report incorrect company information

Hospira Financials and Metrics

Hospira Financials

USDFY, 2013FY, 2014

Cash

798.1 m802.4 m

Accounts Receivable

101.3 m117.3 m

Current Assets

2.8 b3 b
USDFY, 2013FY, 2014

Net Income

(8.3 m)333.2 m

Depreciation and Amortization

171.8 m181.4 m

Inventories

(140 m)(73 m)

Accounts Payable

41.3 m87.5 m
Show all financial metrics
Report incorrect company information

Hospira News and Updates

Injectable Drug Delivery Market Revenue and Value Chain 2015 - 2025

Future Market Insights has announced the addition of the “Injectable Drug Delivery Market: Global Industry Analysis and Opportunity Assessment, 2015 - 2025"report to their offering. Posted via Industry Today. Follow us on Twitter @IndustryToday

Pain Management Devices Market to Show $4.56 Billion by 2021

Global pain management device market expected to reach USD 4.56 by 2021, growing at a CAGR of around 6.8% between 2016 and 2021. Posted via Industry Today. Follow us on Twitter @IndustryToday

Non-PVC IV Bag Global Market 2018: Key Players – Fresenius Kabi, Baxter, B.Braun, Hospira, Technoflex

Non-PVC IV Bag -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

Intravenous Solutions 2018 Global Key Players – Baxter, Hospira, B. Braun Melsungen, Fresenius Kabi, Claris Lifesciences Market Analysis And Forecast To 2025

Wiseguyreports.Com Adds “Intravenous Solutions – Global Market Demand, Growth, Opportunities, Manufacturers, Analysis of Top Key Players and Forecast to 2025” To Its Research Database. Posted via Industry Today. Follow us on Twitter @IndustryToday

Home Infusion Therapy Devices Market is estimated to surpass to US$ 26,747 Million by 2020

The global home infusion therapy devices market was valued at US$ 15,905.1 Million. The market is estimated to surpass to US$ 26,747 Million by 2020, expanding at 9% CAGR over 2014-2020. Posted via Industry Today. Follow us on Twitter @IndustryToday

Infusion Pumps Market is Poised to Reach US$ 4,922 Million by the End of 2025

The global infusion pumps market is estimated at US$ 4,922 Mn in 2025. The market is expected to expand at a CAGR of 5% over the forecast period, 2015–2025 Posted via Industry Today. Follow us on Twitter @IndustryToday
Show more
Report incorrect company information